Skip Navigation

Neuro-Oncology 2000 2(3):159-163; doi:10.1093/neuonc/2.3.159
© 2000 by Society
This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Frederick, L.
Right arrow Articles by James, C. D.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Frederick, L.
Right arrow Articles by James, C. D.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 2000 by the Society forNeuro-Oncology

Analysis of genomic rearrangements associated with EGFRvIII expressionsuggests involvement of Alu repeat elements

Lori Frederick, Greg Eley, Xiao-Yang Wang and C. David James2

Department of Laboratory Medicine and Pathology and Tumor BiologyProgram, Mayo Clinic and Foundation, Rochester, MN 55905

2 Address correspondence and reprint requests to C. David James, Mayo Clinic,200 First St., S.W., Hilton Bldg. Rm. 820-D, Rochester, MN 55905.


   Abstract

We have developed a polymerase chain reaction (PCR)-based strategy for thesynthesis and analysis of rearranged epidermal growth factor receptor(EGFR) fragments associated with the vIII mutant receptor expressedin glioblastomas with EGFR amplification. The sequencing of aberranttumor fragments showed that intragenic deletion rearrangements consistentlyinvolve an approximately 600-bp region in intron 7 of EGFR andseveral rearrangement sites interspersed throughout the large (>100 kb)first intron of this gene. Examination of the intron 7 breakpoint regionrevealed an Alu repeat element, and all intron 7 rearrangement sites werelocated within or downstream of this repeat sequence. Analysis of intron 1 forsimilar sequences resulted in the identification of 11 sites containing>80% homology with parts of the Alu element in intron 7. Reversetranscriptase-PCR and/or Western analysis of the tumors showed the presence ofEGFRvIII cDNAs and/or proteins, respectively, in all cases for which arearranged genomic fragment was generated by long-range PCR. Collectively,these data suggest that EGFR rearrangements, associated with thesynthesis of the most common EGFR mutant, are mediated by a specific sequenceelement.

Received March 8, 2000; Accepted March 30, 2000


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Sci SignalHome page
P. H. Huang, A. M. Xu, and F. M. White
Oncogenic EGFR Signaling Networks in Glioma
Sci. Signal., September 8, 2009; 2(87): re6 - re6.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
M. J. van den Bent, A. A. Brandes, R. Rampling, M. C.M. Kouwenhoven, J. M. Kros, A. F. Carpentier, P. M. Clement, M. Frenay, M. Campone, J.-F. Baurain, et al.
Randomized Phase II Trial of Erlotinib Versus Temozolomide or Carmustine in Recurrent Glioblastoma: EORTC Brain Tumor Group Study 26034
J. Clin. Oncol., March 10, 2009; 27(8): 1268 - 1274.
[Abstract] [Full Text] [PDF]


Home page
Cancer Prevention ResearchHome page
A. F. Gazdar and J. D. Minna
Deregulated EGFR Signaling during Lung Cancer Progression: Mutations, Amplicons, and Autocrine Loops
Cancer Prevention Research, August 1, 2008; 1(3): 156 - 160.
[Full Text] [PDF]


Home page
Cancer Res.Home page
P. J. French, J. Peeters, S. Horsman, E. Duijm, I. Siccama, M. J. van den Bent, T. M. Luider, J. M. Kros, P. van der Spek, and P. A. Sillevis Smitt
Identification of Differentially Regulated Splice Variants and Novel Exons in Glial Brain Tumors Using Exon Expression Arrays
Cancer Res., June 15, 2007; 67(12): 5635 - 5642.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
K.-K. Wong, Y. T.M. Tsang, Y.-M. Chang, J. Su, A. M. Di Francesco, D. Meco, R. Riccardi, L. Perlaky, R. C. Dauser, A. Adesina, et al.
Genome-Wide Allelic Imbalance Analysis of Pediatric Gliomas by Single Nucleotide Polymorphic Allele Array
Cancer Res., December 1, 2006; 66(23): 11172 - 11178.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
H. Ji, X. Zhao, Y. Yuza, T. Shimamura, D. Li, A. Protopopov, B. L. Jung, K. McNamara, H. Xia, K. A. Glatt, et al.
Epidermal growth factor receptor variant III mutations in lung tumorigenesis and sensitivity to tyrosine kinase inhibitors
PNAS, May 16, 2006; 103(20): 7817 - 7822.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
G. Choe, J. K. Park, L. Jouben-Steele, T. J. Kremen, L. M. Liau, H. V. Vinters, T. F. Cloughesy, and P. S. Mischel
Active Matrix Metalloproteinase 9 Expression Is Associated with Primary Glioblastoma Subtype
Clin. Cancer Res., September 1, 2002; 8(9): 2894 - 2901.
[Abstract] [Full Text] [PDF]


Home page
Neuro OncologyHome page
G. D. Eley, J. L. Reiter, A. Pandita, S. Park, R. B. Jenkins, N. J. Maihle, and C. D. James
A chromosomal region 7p11.2 transcript map: Its development andapplication to the study of EGFR amplicons in glioblastoma
Neuro Oncology, April 1, 2002; 4(2): 86 - 94.
[Abstract] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.